Form 8-K - Current report:
SEC Accession No. 0001193125-24-178820
Filing Date
2024-07-15
Accepted
2024-07-15 06:31:38
Documents
48
Period of Report
2024-07-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d840470d8k.htm   iXBRL 8-K 24729
2 EX-99.1 d840470dex991.htm EX-99.1 45694
6 GRAPHIC g840470ex99_1p10g1.jpg GRAPHIC 261348
7 GRAPHIC g840470ex99_1p11g1.jpg GRAPHIC 96054
8 GRAPHIC g840470ex99_1p12g1.jpg GRAPHIC 386520
9 GRAPHIC g840470ex99_1p13g1.jpg GRAPHIC 336021
10 GRAPHIC g840470ex99_1p14g1.jpg GRAPHIC 422203
11 GRAPHIC g840470ex99_1p15g1.jpg GRAPHIC 256326
12 GRAPHIC g840470ex99_1p16g1.jpg GRAPHIC 359378
13 GRAPHIC g840470ex99_1p17g1.jpg GRAPHIC 272058
14 GRAPHIC g840470ex99_1p18g1.jpg GRAPHIC 116729
15 GRAPHIC g840470ex99_1p19g1.jpg GRAPHIC 311183
16 GRAPHIC g840470ex99_1p1g1.jpg GRAPHIC 259060
17 GRAPHIC g840470ex99_1p20g1.jpg GRAPHIC 380999
18 GRAPHIC g840470ex99_1p21g1.jpg GRAPHIC 317524
19 GRAPHIC g840470ex99_1p22g1.jpg GRAPHIC 335719
20 GRAPHIC g840470ex99_1p23g1.jpg GRAPHIC 304789
21 GRAPHIC g840470ex99_1p24g1.jpg GRAPHIC 340704
22 GRAPHIC g840470ex99_1p25g1.jpg GRAPHIC 330220
23 GRAPHIC g840470ex99_1p26g1.jpg GRAPHIC 256010
24 GRAPHIC g840470ex99_1p27g1.jpg GRAPHIC 268055
25 GRAPHIC g840470ex99_1p28g1.jpg GRAPHIC 131040
26 GRAPHIC g840470ex99_1p29g1.jpg GRAPHIC 274620
27 GRAPHIC g840470ex99_1p2g1.jpg GRAPHIC 704894
28 GRAPHIC g840470ex99_1p30g1.jpg GRAPHIC 341438
29 GRAPHIC g840470ex99_1p31g1.jpg GRAPHIC 285779
30 GRAPHIC g840470ex99_1p32g1.jpg GRAPHIC 291253
31 GRAPHIC g840470ex99_1p33g1.jpg GRAPHIC 287691
32 GRAPHIC g840470ex99_1p3g1.jpg GRAPHIC 245211
33 GRAPHIC g840470ex99_1p4g1.jpg GRAPHIC 215952
34 GRAPHIC g840470ex99_1p5g1.jpg GRAPHIC 284146
35 GRAPHIC g840470ex99_1p6g1.jpg GRAPHIC 112044
36 GRAPHIC g840470ex99_1p7g1.jpg GRAPHIC 418276
37 GRAPHIC g840470ex99_1p8g1.jpg GRAPHIC 276132
38 GRAPHIC g840470ex99_1p9g1.jpg GRAPHIC 394694
39 GRAPHIC g840470g0713234402794.jpg GRAPHIC 2767
  Complete submission text file 0001193125-24-178820.txt   13820733

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vrdn-20240715.xsd EX-101.SCH 2890
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrdn-20240715_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrdn-20240715_pre.xml EX-101.PRE 11288
51 EXTRACTED XBRL INSTANCE DOCUMENT d840470d8k_htm.xml XML 3669
Mailing Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

EIN.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36483 | Film No.: 241115826
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)